Medical and Surgical Oncology Lecture- Acute Myeloid Leukemia (AML): Finally Making Progress?

Please join the UNC Cancer Network for an online telehealth lecture with Joshua Zeidner, MD. Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants. We invite anyone interested to view our lectures. Lectures are viewable online via Zoom Webinar or by participating in the lecture at one of our designated viewing sites. Please contact us for more information about Zoom Webinar registration or to be connected with a site coordinator near you.

  • Medical and Surgical Oncology Lecture- Acute Myeloid Leukemia (AML): Finally Making Progress?
  • 2018-05-23T12:00:00-04:00
  • 2018-05-23T13:00:00-04:00
  • Please join the UNC Cancer Network for an online telehealth lecture with Joshua Zeidner, MD. Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants. We invite anyone interested to view our lectures. Lectures are viewable online via Zoom Webinar or by participating in the lecture at one of our designated viewing sites. Please contact us for more information about Zoom Webinar registration or to be connected with a site coordinator near you.
When May 23, 2018 from 12:00 PM to 01:00 PM (EST / UTC-400)
Contact Name
Contact Phone 919-445-1000
Add event to calendar iCal

Zeidner 200 x 200

Joshua Zeidner, MD
Assistant Professor
UNC-Chapel Hill
Clinical Research
UNC Lineberger
UNC School of Medicine

Acute Myeloid Leukemia (AML): Finally Making Progress?

Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development. 

Lecture Objectives:

  • Discuss pathogenesis/etiology of AML

  • Identify diagnostic testing in AML

  • Discuss management of AML in younger and older patient populations in the context of recent drug approvals, highlighting some investigational agents in development

 


Earn FREE Continuing Education Credits with our RN and Allied Health and Medical and Surgical Oncology lectures in the

 

 

Courses like this one are available for a full year beginning two weeks after the initial recording date. 


To Receive Free Continuing Education Credit:
  • Attend the live lecture, either by going to a designated site or by using Zoom (registration link above)
  • After attending the live lecture, complete an evaluation and download your certificate.
  • The instructions and password for the evaluation will be provided after the lecture is over. 
    • If you attend at a designated site, the site coordinator will provide you with the Live Activity Evaluation Instructions. 
    • If you attend via Zoom Webinar, you will receive an email with a link to the Live Activity Evaluation Instructions. 
  • Attendance at the live lecture is required to receive the Live Activity Evaluation Instructions.
Lecture Resources:

UNCCN Site Coordinators:

  • All documents and information for UNCCN Site Coordinators (including connection information, presentation handout, and links to obtain certificates) can be accessed on the UNC Cancer Network Learning Portal.

*Lecture topic subject to change.